Fracture in Duchenne Muscular Dystrophy: Natural History and Vitamin D Deficiency
- PMID: 27221372
- DOI: 10.1177/0883073816650034
Fracture in Duchenne Muscular Dystrophy: Natural History and Vitamin D Deficiency
Abstract
The present study examined the natural history of fracture and vitamin D levels in Duchenne muscular dystrophy patients, who are vulnerable to osteoporosis and fractures. Retrospective analysis of a cohort of 48 Duchenne muscular dystrophy patients revealed that 43% of patients experienced ≥1 fracture. Fracture probabilities at ages 6, 9, 12, and 15 years were 4%, 9%, 31%, and 60% respectively, accelerating around the time of ambulation loss (mean age 11.8 ± 2.7 years). Chronic corticosteroid therapy was utilized in 69% of patients and was associated with all vertebral fractures. A history of vitamin D deficiency occurred in 84%, and 35% were currently deficient. Despite chronic vitamin D supplementation, 38% remained deficient. These results demonstrate that osteoporosis and fracture remain major concerns in Duchenne muscular dystrophy. Bone health should be optimized well before loss of ambulation, however current levels of vitamin D supplementation may be inadequate given high levels of deficiency.
Keywords: Duchenne muscular dystrophy; bone health; fracture; osteoporosis; vitamin D.
© The Author(s) 2016.
Similar articles
-
Vertebral fractures in boys with Duchenne muscular dystrophy.Clin Pediatr (Phila). 2003 May;42(4):353-6. doi: 10.1177/000992280304200408. Clin Pediatr (Phila). 2003. PMID: 12800730
-
Risk Factors for First Fractures Among Males With Duchenne or Becker Muscular Dystrophy.J Pediatr Orthop. 2015 Sep;35(6):640-4. doi: 10.1097/BPO.0000000000000348. J Pediatr Orthop. 2015. PMID: 25379822
-
Retrospective Analysis of Fractures and Factors Causing Ambulation Loss After Lower Limb Fractures in Duchenne Muscular Dystrophy.Am J Phys Med Rehabil. 2020 Sep;99(9):789-794. doi: 10.1097/PHM.0000000000001423. Am J Phys Med Rehabil. 2020. PMID: 32195737
-
Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk?Pharmacotherapy. 2010 Mar;30(3):254-64. doi: 10.1592/phco.30.3.254. Pharmacotherapy. 2010. PMID: 20180609 Review.
-
[Secondary osteoporosis or secondary contributors to bone loss in fracture. Vitamin D deficiency and fracture].Clin Calcium. 2013 Sep;23(9):1313-9. Clin Calcium. 2013. PMID: 23999368 Review. Japanese.
Cited by
-
Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study.Adv Ther. 2022 Jul;39(7):3308-3315. doi: 10.1007/s12325-022-02179-1. Epub 2022 May 25. Adv Ther. 2022. PMID: 35614293 Free PMC article.
-
Fractures in Hereditary Neuromuscular Disorders: Frequency, Risk Factors, and Implications.Eur J Neurol. 2025 Mar;32(3):e70099. doi: 10.1111/ene.70099. Eur J Neurol. 2025. PMID: 40040345 Free PMC article.
-
Effects of Neurological Disorders on Bone Health.Front Psychol. 2020 Nov 30;11:612366. doi: 10.3389/fpsyg.2020.612366. eCollection 2020. Front Psychol. 2020. PMID: 33424724 Free PMC article. Review.
-
Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review).Exp Ther Med. 2021 May;21(5):447. doi: 10.3892/etm.2021.9875. Epub 2021 Mar 1. Exp Ther Med. 2021. PMID: 33777191 Free PMC article. Review.
-
Increased Rates of Vitamin D Insufficiency in Boys With Duchenne Muscular Dystrophy Despite Higher Vitamin D3 Supplementation.Glob Pediatr Health. 2019 Mar 15;6:2333794X19835661. doi: 10.1177/2333794X19835661. eCollection 2019. Glob Pediatr Health. 2019. PMID: 30906820 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical